CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Intra-cellular Therapies, Inc.  (ITCI)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 

Intra-cellular Therapies's Quick Ratio

ITCI's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:                        

ITCI Quick Ratio (Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
(Mar 31 2016)
I. Quarter
Y / Y Current Liabilities Change 82.4 % 68.15 % 1254.48 % 107.99 % -38.69 %
Y / Y Cash & cash equivalent Change -19.36 % -19.17 % 5.3 % 117.02 % 93.88 %
Quick Ratio MRQ 22.54 36.47 3.82 22.84 50.98
Overall Ranking # 126 # 72 # 636 # 129 # 66
Seq. Current Liabilities Change 54.94 % -92.51 % 625.91 % 116.63 % 42.84 %
Seq. Cash & cash equivalent Change -4.25 % -28.58 % 21.48 % -2.93 % -4.03 %



Quick Ratio first quarter 2017 Comment
Due to increase in Current Liabilities in the first quarter 2017, Quick Ratio fell to 22.54 below Intra-cellular Therapies, Inc. average.

Within Major Pharmaceutical Preparations industry 12 other companies have achieved higher Quick Ratio than Intra-cellular Therapies in first quarter 2017. While Quick Ratio total ranking has deteriorated compare to previous quarter from 72 to 126.

Explain Quick Ratio?
What are ITCI Segments?
See Quick Ratio ITCI on the trailing twelve month basis
Quick Ratio first quarter 2017 Company Ranking
Within: No.
Industry # 13
Sector # 25
S&P 500 # 126


Quick Ratio Statistics
High Average Low
75.87 26.47 0
(Dec 31 2015)   (Jun 30 2013)


You need to upgrade your Flash Player


Financial Statements
Intra-cellular Therapies's Current Liabilities $ 16 Millions Visit ITCI's Balance sheet
Intra-cellular Therapies's Cash & cash equivalent $ 368 Millions Visit ITCI's Balance sheet
Source of ITCI's Sales Visit ITCI's Sales by Geography




Companies with similar Quick Ratio in the quarter endingMar 31 2017, within Major Pharmaceutical Preparations Industry Quick RatioMar 31 2017 MRQ Cash & cash equivalentMar 31 2017 MRQ Current Liabilities
Flex Pharma, Inc.  58.23 $ 52.815  Millions$ 0.907  Millions
Corvus Pharmaceuticals, Inc.  50.42 $ 122.064  Millions$ 2.421  Millions
Prothena Corp Plc  42.32 $ 506.550  Millions$ 11.970  Millions
Abeona Therapeutics Inc.  30.61 $ 63.212  Millions$ 2.065  Millions
Syros Pharmaceuticals, Inc.  27.67 $ 70.494  Millions$ 2.548  Millions
Dipexium Pharmaceuticals, Inc.  26.98 $ 12.471  Millions$ 0.462  Millions
Endocyte Inc  25.95 $ 127.562  Millions$ 4.915  Millions
Aimmune Therapeutics, Inc.  24.09 $ 246.247  Millions$ 10.223  Millions
Sierra Oncology, Inc.  23.94 $ 125.025  Millions$ 5.222  Millions
Loxo Oncology, Inc.  23.09 $ 240.315  Millions$ 10.408  Millions
Kindred Biosciences, Inc.  22.88 $ 65.138  Millions$ 2.847  Millions
Sophiris Bio Inc.  22.84 $ 25.694  Millions$ 1.125  Millions
Intra-cellular Therapies, Inc.  22.54 $ 367.781  Millions$ 16.319  Millions
Inotek Pharmaceuticals Corporation  21.77 $ 114.705  Millions$ 5.268  Millions
Medicinova Inc  21.17 $ 21.637  Millions$ 1.022  Millions
Aquinox Pharmaceuticals, Inc  20.88 $ 121.581  Millions$ 5.824  Millions
Ra Pharmaceuticals, Inc.  19.86 $ 105.373  Millions$ 5.307  Millions
Pain Therapeutics Inc  19.55 $ 17.264  Millions$ 0.883  Millions
Dermira, Inc.  19.46 $ 414.627  Millions$ 21.311  Millions
Enanta Pharmaceuticals Inc  19.18 $ 175.573  Millions$ 9.154  Millions
Catalyst Pharmaceuticals, Inc.  19.17 $ 36.527  Millions$ 1.906  Millions
Chimerix Inc  18.73 $ 161.695  Millions$ 8.632  Millions
Biospecifics Technologies Corp  18.39 $ 47.872  Millions$ 2.603  Millions
Otonomy, Inc.  17.90 $ 168.124  Millions$ 9.390  Millions
Global Blood Therapeutics, Inc.  16.57 $ 244.324  Millions$ 14.747  Millions
Scynexis Inc  16.35 $ 54.899  Millions$ 3.358  Millions
Xenon Pharmaceuticals Inc.  16.16 $ 58.027  Millions$ 3.591  Millions
Kura Oncology, Inc.  16.04 $ 59.153  Millions$ 3.688  Millions
Aduro Biotech, Inc.  14.76 $ 353.961  Millions$ 23.975  Millions
Aeglea Biotherapeutics, Inc.  14.62 $ 57.868  Millions$ 3.957  Millions


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com